Ra Pharmaceuticals Inc (RARX) Stock Analyst Ratings
NASDAQ:RARX - Nasdaq -
ChartMill assigns a Buy % Consensus number of 60% to RARX. The Buy consensus is the weighted average rating of the current analysts ratings.
RARX was analyzed by 7 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about RARX.
In the previous month the buy percentage consensus was at a similar level.
RARX was analyzed by 7 analysts. More opinions would make the average more meaningful.